Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Orthotopic Liver Transplantation”

104 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 104 results

Post-approval studies (Phase 4)Study completedNCT00998426
What this trial is testing

Evaluating Blood Glucose Levels During Infusion With HepaGam B (HBIG) in Post-liver Transplant Patients

Who this might be right for
Hepatitis B
Georgetown University 5
Not applicableEnded earlyNCT03170869
What this trial is testing

Bridge to Orthotopic Liver Transplantation (OLT) - Surefire Precision vs Endhole Embolization With DEBTACE

Who this might be right for
Hepatocellular Carcinoma of the LiverSubjects Eligible for Liver Transplantation
University of Colorado, Denver 11
Not applicableStudy completedNCT05209048
What this trial is testing

Risk Factors and a nOmogram of Venous thromboEmbolism in Patients After liveR Transplantation(ROVER Study)

Who this might be right for
Venous ThromboembolismLiver Transplantation
Beijing Tsinghua Chang Gung Hospital 356
Not applicableEnrolling By InvitationNCT07744230
What this trial is testing

Prometheus: Prophylactic Mesh After OLtx for Hernia Reduction Study.

Who this might be right for
Incisional Hernia/Prevention and Control
University of Rome Tor Vergata 100
Not applicableLooking for participantsNCT06718517
What this trial is testing

Impact of a TDM-guided ECPA Program for Optimizing Pharmacodynamic Target Attainment of Continuous Infusion Beta-lactam-based Regimen

Who this might be right for
Liver Transplant Infection
IRCCS Azienda Ospedaliero-Universitaria di Bologna 65
Testing effectiveness (Phase 2)UnknownNCT05355155
What this trial is testing

Bevacizumab Biosimilar Plus FOLFOX4 in the Treatment of Recurrent HCC After Liver Transplantation

Who this might be right for
Post-orthotopic Liver TransplantationHepatocellular Carcinoma Recurrent
The First Affiliated Hospital with Nanjing Medical University 15
Not applicableStudy completedNCT01339078
What this trial is testing

Trial Comparing Kaffes Stent With Plastic Prosthesis in the Treatment of Anastomotic Biliary Strictures Post Orthotopic Liver Transplantation

Who this might be right for
Biliary Strictures Post Liver Transplantation
University Hospital, Ghent 5
Not applicableStudy completedNCT02635347
What this trial is testing

Remote Ischemic Conditioning (RIC) in Recipients of Brain Death Donor Livers - A Feasibility and Safety Study

Who this might be right for
Liver FailureCarcinoma, Hepatocellular
Rutgers, The State University of New Jersey 31
Not applicableStudy completedNCT01271179
What this trial is testing

Study of Sequential Perfusion of Liver Grafts to Prevent Nonanastomotic Biliary Strictures After Liver Transplantation

Who this might be right for
Liver TransplantationTransplant Recipient
Shanghai Jiao Tong University School of Medicine 141
Not applicableEnded earlyNCT04316468
What this trial is testing

Cardiac Strain Using Speckle Tracking Echocardiography During Orthotopic Liver Transplantation

Who this might be right for
Liver Transplant DisorderReperfusion Injury
Mayo Clinic 20
Post-approval studies (Phase 4)Study completedNCT02123108
What this trial is testing

Safety and Efficacy of Basiliximab, Delayed Dose Tacrolimus Plus ECMPA (Enteric Coated Mycophenolic Acid) Following Liver Transplantation

Who this might be right for
Liver Transplantation
University of California, Los Angeles 59
Not applicableNot Yet RecruitingNCT07658794
What this trial is testing

Intraoperative Assessment of Microcirculatory Function Using Vascular Occlusion Test During Liver Transplantation

Who this might be right for
Liver CirrhosisEarly Allograft Dysfunction
Ippokrateio General Hospital of Thessaloniki 50
Not applicableEnded earlyNCT03479125
What this trial is testing

Post-Treatment Follow-up Study for Liver Disease Subjects With or Without Cirrhosis After Receiving Emricasan or Placebo

Who this might be right for
Liver DiseasesLiver FibrosisLiver Cirrhosis+3 more
Conatus Pharmaceuticals Inc. 40
Testing effectiveness (Phase 2)UnknownNCT00450398
What this trial is testing

YSPSL for Prevention of Delayed Graft Function in Cadaveric Liver Transplantation

Who this might be right for
Liver Diseases
Y's Therapeutics, Inc. 12
Not applicableStudy completedNCT05037838
What this trial is testing

Strain Analysis for Assessment of Myocardic Dysfunction During Orthotopic Liver Transplantation

Who this might be right for
Myocardial DysfunctionLiver Transplant; Complications
Hospices Civils de Lyon 60
Not applicableStudy completedNCT04764266
What this trial is testing

Glycocalyx During Normothermic Machine Perfusion

Who this might be right for
GlycocalyxLiver Transplantation
Medical University Innsbruck 30
Not applicableStudy completedNCT03563404
What this trial is testing

Portal Blood Flushes in the Peri-Reperfusion Stage of Liver Transplantation

Who this might be right for
Liver Disease
Medical University of South Carolina 20
Post-approval studies (Phase 4)WithdrawnNCT00167557
What this trial is testing

Orthotopic Liver Transplant (OLT) Recipients With Hepatitis C Virus (HCV) Under Preemptive Treatment

Who this might be right for
Hepatitis C
The University of Texas Health Science Center, Houston
Post-approval studies (Phase 4)Ended earlyNCT01592006
What this trial is testing

Pegylated Interferon, Ribavirin, Telaprevir in Hepatitis C Virus Infection in Orthotopic Liver Transplant Recipients

Who this might be right for
Hepatitis C
University of Chicago 3
Not applicableStudy completedNCT03124641
What this trial is testing

HOPE for Human Extended Criteria and Donation After Brain Death Donor (ECD-DBD) Liver Allografts

Who this might be right for
Hepatocellular InjuryLiver Transplant
University Hospital, Aachen 46
Next Page